Matilda Modigh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matilda Modigh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Bartholdson
Astrid Lindgren's Children's Hospital Karolinska University Hospital Stockholm Sweden
2 shared publications - Arvind Kumar
Department of Computational Science and Technology, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, 11428 Stockholm, Sweden
1 shared publication - Elina Tayebi
School of Electrical Engineering and Computer Science KTH, Royal Institute of Technology Stockholm Sweden
1 shared publication - Heléne E. K. Sundelin
Department of Pediatrics, University Hospital, Linköping, Sweden
1 shared publication Heléne Sundelin
Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Karolinska Institutet, Dept. of Women's and Children's Health, Stockholm, Sweden
1 shared publicationRonny Wickström
Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Karolinska Institutet, Dept. of Women's and Children's Health, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Wiley in Epileptic Disorders
Identifying drug‐resistant epilepsy using Swedish National Patient Registry data
Background: Approximately 30% of individuals with epilepsy are drug‐resistant, suffering low quality of life and should be evaluated for other treatment modalities. Drug‐resistant epilepsy has no specific diagnostic code, making identification in national healthcare registers challenging and limiting epidemiological research based on register data. Methods: To define our cohort, we used 1320 individuals from the Swedish National Epilepsy Surgery Register (SNESUR) as index individuals. Each index individual was matched with up to 17 individuals with epilepsy of similar age and diagnosis year in the Swedish National Patient Register. After excluding all SNESUR individuals, the study cohort consisted of 21 393 individuals, a cohort broadly representative of the general epilepsy population. Data on diagnoses, procedures, healthcare contacts, and dispensed antiseizure medications were obtained from national registers. A distance‐based ranking algorithm was developed and validated against medical records. Three machine‐learning classifiers were then trained and tested using a proxy of the International League Against Epilepsy definition of drug‐resistant epilepsy. Results: The ranking algorithm showed high performance for identifying drug‐resistant epilepsy, with a positive predictive value (PPV) of 86.2% (95% CI: 0.81–0.90). Out of the three machine‐learning classifiers, Gradient Boosting Machine achieved the highest F1‐score of 0.762 (along with PPV = 0.781, sensitivity = 0.744, specificity = 0.820, area under the precision‐recall curve = 0.858). The most significant variables found were “total visits to outpatient clinic due to epilepsy,” “age of onset of epilepsy,” “total admissions due to epilepsy,” and “total days of admission due to epilepsy.” Conclusion: Both the ranking algorithm and machine‐learning approaches showed good performance in register‐based phenotyping of drug‐resistant epilepsy using routinely collected register data, supporting their use in epidemiologic research.
- 18 September 2026
- Published by Wiley in Epileptic Disorders
Open AccessIdentifying drug‐resistant epilepsy using Swedish National Patient Registry data
Background: Approximately 30% of individuals with epilepsy are drug‐resistant, suffering low quality of life and should be evaluated for other treatment modalities. Drug‐resistant epilepsy has no specific diagnostic code, making identification in national healthcare registers challenging and limiting epidemiological research based on register data. Methods: To define our cohort, we used 1320 individuals from the Swedish National Epilepsy Surgery Register (SNESUR) as index individuals. Each index individual was matched with up to 17 individuals with epilepsy of similar age and diagnosis year in the Swedish National Patient Register. After excluding all SNESUR individuals, the study cohort consisted of 21 393 individuals, a cohort broadly representative of the general epilepsy population. Data on diagnoses, procedures, healthcare contacts, and dispensed antiseizure medications were obtained from national registers. A distance‐based ranking algorithm was developed and validated against medical records. Three machine‐learning classifiers were then trained and tested using a proxy of the International League Against Epilepsy definition of drug‐resistant epilepsy. Results: The ranking algorithm showed high performance for identifying drug‐resistant epilepsy, with a positive predictive value (PPV) of 86.2% (95% CI: 0.81–0.90). Out of the three machine‐learning classifiers, Gradient Boosting Machine achieved the highest F1‐score of 0.762 (along with PPV = 0.781, sensitivity = 0.744, specificity = 0.820, area under the precision‐recall curve = 0.858). The most significant variables found were “total visits to outpatient clinic due to epilepsy,” “age of onset of epilepsy,” “total admissions due to epilepsy,” and “total days of admission due to epilepsy.” Conclusion: Both the ranking algorithm and machine‐learning approaches showed good performance in register‐based phenotyping of drug‐resistant epilepsy using routinely collected register data, supporting their use in epidemiologic research.
- Open Access
- 27 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110664
Understanding Children’s experiences of Long-Term Video-Electroencephalography monitoring in Drug-Resistant epilepsy
- 27 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110664
Open AccessUnderstanding Children’s experiences of Long-Term Video-Electroencephalography monitoring in Drug-Resistant epilepsy